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Basophils are, together with mast cells, typical innate effector cells of allergen-induced
IgE-dependent allergic diseases. Both cell types express the high-affinity receptor for
IgE (Fc"R1), release histamine, inflammatory mediators, and cytokines following Fc"R1
cross-linking. Basophils are rare granulocytes in blood, lymphoid, and non-lymphoid
tissues, and the difficulties to detect and isolate these cells has hampered the study of
their biology and the understanding of their possible role in pathology. Furthermore, the
existence of other Fc"R1-expressing cells, including professional Ag-presenting dendritic
cells, generated some controversy regarding the ability of basophils to express MHC
Class II molecules, present Ag and drive naïve T cell differentiation into Th2 cells. The
focus of this review is to present the recent advances on the interactions between
basophils and peripheral blood and tissue memory Th1, Th2, and Th17 cells, as well
as their potential role in IgE-independent non-allergic chronic inflammatory disorders,
including human inflammatory bowel diseases. Basophils interactions with the innate
players of IgE-dependent allergic inflammation, particularly innate lymphoid cells, will also
be considered. The previously unrecognized function for basophils in skewing adaptive
immune responses opens novel perspectives for the understanding of their contribution
to the pathogenesis of inflammatory diseases.
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Basophils in Type 2 Immune Responses
Basophils represent <1% of all blood leukocytes. Together with mast cells, they are regarded as
typical effector cells of IgE-dependent allergic inflammation (1, 2). Because both types of cells
express high levels of the high-affinity receptor for IgE (Fc"R1), and rapidly release histamine
and inflammatory mediators upon cross-linking of Fc"R1 by IgE-allergen complexes, basophils
were long considered as redundant granulocytes lacking unique functions (3). Until recently, the
investigations of the functional properties of basophils have been hampered by the difficulty of
detecting and purifying these rare cells in blood and tissues from mice and humans (4). Despite the
development of transgenic mice (IL-4-eGFP, Basoph8) that allow the tracking or transient depletion
of basophils in vivo, conflicting results were generated regarding the antigen-presenting function of
basophils and their ability to trump DCs in the priming of Th2 responses (5–8). However, it was
reported that cooperation between highly purified murine basophils and DCs, isolated from blood
or lungs, is required to induce in vitro Th2 cell differentiation (9, 10). In this context, DCs ensure
naïve T cell proliferation and basophils provide IL-4 to drive Th2 polarization. As a consequence,
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a careful exclusion of trace amounts of MHC class II+Fc"R1+
DCs from basophils preparation is mandatory to draw valid con-
clusions about any yet unrecognized in vitro function of these rare
cells, especially in human studies (11).
Despite their low frequency in blood, increased numbers of
basophils were detected in the tissues of several IgE-dependent
allergic diseases that include allergic rhinitis, atopic dermatitis,
and asthma (2, 12). How basophils are attracted to the site of
allergen challenge remains to be clarified. Histamine and PGD2,
which are produced by mast cells, as well as IL-3 secreted by
activated T cells have been proposed to play crucial roles in the
recruitment of basophils to tissues, since basophils express his-
tamine receptors, CRTH2 (i.e., PGD2 receptor) and IL-3 receptors
(13–15). In tissues, basophils may interact with resident memory
T cells, as demonstrated by two-photon microscopy (8). Hence,
prolonged contacts between basophils and T cells occurred in the
inflamed lungs but not in the mediastinal lymph nodes (LNs) of
parasite-infectedmice. The same study also revealed that activated
T cells induced IL-4 secretion by basophils in affected lungs.
Optimal IL-4 production by basophils required a direct cell/cell
contact, as well as the presence of IL-3, a cytokine that pro-
motes expansion and survival of basophils. Conversely, in vitro
interactions between pulmonary basophils and lung CD4+ T cell
promoted IL-4-dependent T cell survival and amplified release of
Th2 cytokines, without inducing memory T cell expansion (9). In
experimental asthma, transfer of lung basophils worsens ongoing
Th2 responses by increasing airway inflammation and local IL-4
and IL-13 expression (9). Furthermore, human basophils increase
IL-4 expression in effector memory T cells in vitro. Notably,
responding T cells mainly included CRTH2+ cells, corroborating
the in vivo and in vitro data seen in mice. In addition to Th2
cells that produce IL-4, IL-5, and IL-13, double IL-4- and IL-
17-expressing memory CD4+ T cells were detected in severe
asthmatic patients and in lungs of mice developing experimental
asthma (16). In contrast, human basophils were not reported
to promote the generation of Th2/Th17 double positive cells.
The basophil enhancing effect on memory Th2 responses was
partially contact dependent, but did not involve OX40/OX40L,
CTLA4/B7family, and CD2/LFA3 interactions. Because IL-3-
stimulated basophils express RANKL and activated Th cells may
express RANK (17, 18), we speculate that RANK–RANKL pairs
of molecules may represent other potential candidates involved in
basophil-T cell interactions.
Cellular aggregates made of basophils and memory CD4+
T cells were detected in the dermis of patients with atopic der-
matitis and in a mouse model of TSLP-mediated contact der-
matitis, underlying the key role of basophils in T cell-mediated
skin allergic disorders (19). However, basophils may regulate
type 2 inflammatory responses by interacting with cells other
than T cells. Indeed, innate immune cells, such as macrophages,
innate lymphoid type 2 (ILC2), and eosinophils, are major con-
tributors of allergic lung and skin inflammatory responses (20,
21). Moreover, keratinocyte-derived TSLP activates basophils that
results in local recruitment, activation, and proliferation of ILC2,
which is mediated by basophil-derived IL-4 (19). This mechanism
initiates experimental atopic dermatitis and appears essential for
the development of food allergy induced by the application of
food antigen to inflamed skin (22). Furthermore, the interactions
of activated basophils with ILC2, fibroblasts, and/or endothelial
cells regulate recruitment of eosinophils in experimental models
of contact dermatitis and allergic asthma (21, 23).
Taken collectively, these finding indicate that, although
basophils do not appear to initiate IgE-dependent allergic disease,
the interaction between basophil and memory T cell in inflamed
tissues may be bidirectional, thus contributing to the exacerbation
of chronic allergic airway inflammation at late stages. In support of
this, asthmatic patients are successfully treated by administration
of Omalizumab, a monoclonal antibody to IgE that prevents IgE
binding to Fc"R1 and regulates basophil homeostasis (24). It has
been suggested that its therapeutic efficacy largely result from
its effect on basophils, since these cells have a much shorter life
than mast cells. In fact, the improved clinical outcome of allergic
patients following Omalizumab therapy was associated with a
reduction in circulating basophil numbers (24).
Basophils in IgE-Independent
Th Responses
Basophils were historically associated exclusively with IgE-
dependent allergic disorders. However, TSLP-activated basophils
induce and perpetuate experimental eosinophilic esophagitis
(EoE), whichmay be triggered in the absence of IgE andmast cells
(25). Notably, the circulating number of basophils is increased
in patients with EoE. Similarly, increased numbers of basophils
are observed in blood of patients with chronic inflammatory
bowel diseases (IBD) (26). Basophilia is found in both Crohn’s
disease (CD) and ulcerative colitis (UC), the two main chronic
relapsing IBD types that are associated with Th17/Th1 and Th17
or Th2 cells, respectively (27). Strikingly, increased percentages
of basophils, but not of mast cells are found in the inflamed
relative to the non-inflamed colonic mucosa in both CD and
UC patients (26). In contrast, basophils are not detected in the
intestinal mucosa of non-IBD individuals. The accumulation of
basophils in the inflamed colons of IBD patients suggests that
these rare cells contribute to disease pathogenesis by influencing
pathogenic T cell responses in tissues.
Indeed, similar to their ability to amplify human mem-
ory Th2 responses, basophils promote memory Th17 responses
in vitro (11). Blood basophils as well as basophils isolated
from inflamed colonic mucosa or the mesenteric LNs of IBD
patients favor the emergence of memory IL-17+, IL-17+/IFN-
γ
+ but not IFN-γ+ single positive Th cells (26). Activation of
CD4+ T lymphocytes generates functionally distinct antigen-
experienced T cells, namely, effector memory CD62LlowCCR7 
(TEM) that migrate to peripheral tissues and central memory
CD62LhighCCR7+ (TCM) T cells, which retain the ability to enter
LNs (28). Thus, basophils activated by either IL-3, IL-33, or
TSLP increase Th17 and Th17/Th1 responses by IL-2-stimulated
TEM in the absence of APC, as well as by TCR-stimulated TCM
isolated from blood, which mimic memory T cell activation in
mucosa and lymphoid tissues, respectively (11). More specif-
ically, basophils promote cytokine production by autologous
TEM cells in a contact-independent manner that involves the
ERK1/2-pathway. Basophil-derived histamine partially increases
IL-17 expression through H2 and H4, but not H1 receptors.
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Interestingly, histamine alone cannot replace basophils in their
pro-Th17 activity.
Basophils also enhance IL-22 production by TEM cells but not
TCM (11). However, Sharma et al. (29, 30) reported that human
basophils lack the ability to drive IL-22 or IL-17 memory CD4+
T cell responses. The reasons for the apparent discrepancies might
at least result from the analysis of unfractionated stimulated
CD45RO+CD25  CD4+ T cells, which mainly comprises TCM,
in co-culture with IL-3-activated basophils. Also, the purity of
basophils was 94 5% in the latter studies (29, 30), in contrast
to>99% purity in the former studies (11, 26), further highlighting
the importance of assessing highly purified basophil preparations.
Lymphoid tissues represent the major site of memory T cells in
the body relative to circulating pool (31). It is therefore essential,
whenever feasible in humans, to assess the functions of T cells
that are found in tissues. Basophils enhance Th17 and Th17/Th1
responses by TCM andTEM CD4T cells isolated frommLNs of IBD
patients (26). Furthermore, a small number of tissuememory TEM
express CCR7 in inflamed tissues and CCR7+ TEM cells are prone
to exit the tissues and re-circulate (32, 33). Notably, CCR7+ TEM
cells are the preferential targets of basophils for enhancing Th17
responses (26). A recent study demonstrates that CCR7 expression
controls intestinal Th17 and Th1 balance in a model of TNF-α
driven Crohn’s-like ileitis (34). The CCR7-deficient mice or mice
treated with anti-CCR7 mAb develop an exacerbated ileo-colitis,
which is associated with retention of Th effectors in intestinal and
extra-intestinal tissues, suggesting that recirculation of CCR7+
TEM contribute to intestinal homeostasis.
Immunoregulatory Activity of Basophils
Although basophils clearly amplify allergic skin and airway
inflammation, several studies showed that these rare cells might
also exert anti-inflammatory activities in the context of autoim-
mune disease, contact dermatitis, as well as colitis. In a mouse
model of arthritis, IL-4 production by IL-33-activated basophils
was found to enhance expression of the inhibitory Fcγ Recep-
tor (FcγRIIb) on inflammatory macrophages and mediates the
immunosuppressive response elicited by injection of intravenous
immunoglobulin (IVIG) (35). A recent report indicates that
upon IL-33 and IgE triggering, human basophils down-modulate
monocyte activation in vitro (36). Furthermore, basophil-derived
IL-4 significantly attenuates the intensity of skin inflamma-
tion by mediating the differentiation of inflammatory mono-
cytes into alternatively activated M2 macrophages that are
endowed with an immunosuppressive and anti-inflammatory
activity (37).
Basophils display immunoregulatory activity by enhancing the
suppressive activity of FOXP3-expressing regulatory T cells (Treg)
in vivo and in vitro (38). In a mouse model of contact hyper-
sensitivity, basophils mediate UVB-induced immune suppression
by increasing Treg function and this immunosuppressive effect
is reduced in amphiregulin (AREG)-deficient mice (39). Indeed,
basophils express AREG, an epidermal cell growth factor-like
cytokine that enhances Treg function (40). Finally, the in vivo
role of basophils in pathologies affecting the gastrointestinal tract
remains to be clarified. Adirect pathogenic role has been proposed
for murine basophils in experimental EoE, as well as in allergen-
induced colitis in a humanized mice model (25, 41). On the other
hand, basophils depletion aggravates colitis induced by adoptive
transfer of T cells in lymphopenic mice (42).
Concluding Remarks
Overall, the in vivo function of mucosal or lymphoid human
basophils warrants further investigations in allergic diseases,
CD, and UC. Basophils accumulate in inflamed tissues in
IgE-dependent, as well as IgE-independent inflammatory disor-
ders whereby they may directly interact with memory T cells
to augment Th2, Th17, and Th17/Th1 effector responses. The
accumulation of basophils in tissues indicates that they may
contribute to the aggravation and flare up of the disease. Con-
versely, their increased numbers may as well reflect a nega-
tive regulatory feedback mechanism to dampen inflammation.
Nonetheless, basophils represent an attractive therapeutic target
for patients with chronic inflammatory disorders. This opens
therapeutic avenues by targeting basophils and histamine using
the clinically safe non-degranulating anti-IgE human monoclonal
antibody (Omalizumab) (43) or selective anti-histamine receptor
drugs (44).
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